Cohen Jacob D. sold MGRX
March 16, 2026 · Form 4 insider transaction
Cohen Jacob D. sold 50,000 shares of Mangoceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as disposition to the issuer and disclosed on an SEC Form 4, filed 4 days after the transaction.
Footnotes
On March 16, 2026, the Issuer's Board of Directors, with the recommendation and approval of the Compensation Committee of the Board of Directors, approved an option repricing (the "Repricing") whereby the Reporting Person's options were repriced on March 16, 2026 (the "Effective Date") with a new exercise price of $0.45, which exceeded the closing price on Nasdaq as of the Effective Date. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable.; A total of 1/3 of such options vested on each of September 1, 2023, 2024 and 2025.; Represents Mr. Cohen's direct ownership of the Issuer.